Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Avolynt, Inc. logo — company profile

Avolynt, Inc.

Founded 2015 2 employees Grant Total: $75.00K Biotechnology, Health Care

General Information

Company Name Avolynt, Inc.
Founded Year 2015
Employees 2
Industries Biotechnology, Health Care
Funding Stage Grant
Social

Get notified when Avolynt, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Avolynt, Inc.

Avolynt, Inc. is a clinical stage pharmaceutical company founded in 2015, specializing in the development of innovative therapeutics for the treatment of rare and metabolic diseases. Their primary focus lies within the Biotechnology and Health Care industries. Recently, the company received a significant $75.00K grant investment on 22 September 2022 from the One North Carolina Small Business Program. This notable injection of funds can potentially fuel their continued research and development efforts as they strive to make meaningful advancements in the field of pharmaceuticals.

Taxonomy: pharmaceutical, clinical stage, therapeutics, rare disease, metabolic disease

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 22 Sep 2022

Avolynt, Inc. Alternatives & Competitors

Avolynt, Inc. vs
RespiQ
RespiQ The Netherlands

Smart breath testing for better health.

Grant
11 employees
Biotechnology
Avolynt, Inc. vs
MitoRx Therapeutics
MitoRx Therapeutics United Kingdom

Developing new treatments to restore healthy mitochondrial metabolism in patients living with high-r...

Seed
17 employees
Biotechnology, Health and Wellness
Avolynt, Inc. vs
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. United States

Developing a potentially disease-modifying, new drug treatment for Alzheimer’s and other neurodegene...

Series Unknown
12 employees
Biotechnology

FAQ About Avolynt, Inc.

Avolynt is a clinical stage pharmaceutical company developing novel therapeutics for the treatment of rare and metabolic disease.
Avolynt, Inc. was founded in 2015.
Avolynt, Inc. operates in the following industries: Biotechnology, Health Care.
Avolynt, Inc. has approximately 2 employees.
Avolynt, Inc. has completed 1 funding round, raising a total of $75.00K. The latest funding stage is Grant.
Top alternatives and competitors to Avolynt, Inc. include RespiQ, MitoRx Therapeutics, T3D Therapeutics, Inc., G3P, Parkinson's Association of San Diego. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avolynt, Inc. and RespiQ are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Avolynt, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy